{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:00:35Z","timestamp":1760043635863,"version":"3.37.3"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foundation of Health Commission of Hubei Province","award":["WJ2019M235"],"award-info":[{"award-number":["WJ2019M235"]}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["2016CFB405"],"award-info":[{"award-number":["2016CFB405"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Apatinib is a novel anti-angiogenic agent that targets vascular endothelial growth factor receptor-2, thereby inhibiting tumor angiogenesis, and is effective in the treatment of brain metastases (BM) and peritumoral brain edema (PTBE). There are no previous reports of combination therapy with apatinib and fractionated stereotactic radiotherapy (FSRT) for BM from primary lung mucoepidermoid carcinoma (MEC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient Concerns:<\/jats:title>\n            <jats:p>A 63-year-old man underwent left lower lobectomy and mediastinal lymph node dissection in April 2018.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Postoperative pathology demonstrated high-grade MEC. The patient developed 3 BM with PTBE 3 months after undergoing surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient received a combination of FSRT and apatinib (250\u2013500\u200amg\/d) as maintenance therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The 3 BM showed nearly complete responses, and the PTBE areas shrank visibly. A new BM lesion occurred 7 months after the first FSRT and was treated with a second dose of FSRT. The patient developed extensive metastasis and atelectasis 9 months later. He died of pulmonary infection in December 2019. The overall survival time was 20 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Limited BM from primary lung MEC may be treated effectively with combination therapy with apatinib and FSRT when chemotherapy alone is not effective or tolerated. Further studies are needed to investigate the clinical outcomes and toxicities associated with the treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022925","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T01:03:16Z","timestamp":1603501396000},"page":"e22925","source":"Crossref","is-referenced-by-count":5,"title":["Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma"],"prefix":"10.1097","volume":"99","author":[{"given":"Hongxia","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.ijrobp.2012.08.007","article-title":"Use of stereotactic radiosurgery of brain metastases from non-small cell lung cancer in the United States","volume":"85","author":"Halasz","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/14656566.2015.981526","article-title":"Apatinib for the treatment of gastric cancer","volume":"16","author":"Geng","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"e7358","DOI":"10.1097\/MD.0000000000007358","article-title":"Apatinib in refractory radiation-induced edema: a case report","volume":"96","author":"Hu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/15384047.2018.1491502","article-title":"Successful treatment using apatinib in intractable brain edema: a case report and literatures review","volume":"19","author":"Song","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000331179","article-title":"Whole-brain radiation therapy of brain metastasis","volume":"25","author":"Sahgal","year":"2012","journal-title":"Prog Neurol Surg"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/cncr.26515","article-title":"A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases","volume":"118","author":"Tsao","year":"2012","journal-title":"Cancer"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.radonc.2014.07.007","article-title":"Patterns of distant brain recurrences after radiosurgery alone for newly diagnosed brain metastases: implications for salvage therapy","volume":"112","author":"Zindler","year":"2014","journal-title":"Radiother Oncol"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fonc.2018.00154","article-title":"Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions","volume":"8","author":"Hartgerink","year":"2018","journal-title":"Front Oncol"},{"key":"R10-20230916","first-page":"5797","article-title":"Brain metastases in NSCLC\u2014are TKIs changing the treatment strategy?","volume":"35","author":"Dempke","year":"2015","journal-title":"Anticancer Res"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/1078-0432.CCR-16-0399","article-title":"Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity","volume":"22","author":"Ballard","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ctrv.2015.05.005","article-title":"Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: a systematic review","volume":"41","author":"Hendriks","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1586\/14737175.2013.856264","article-title":"Antiangiogenic therapy for high-grade gliomas: current concepts and limitations","volume":"13","author":"De Bonis","year":"2013","journal-title":"Expert Rev Neurother"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CMR.0000000000000389","article-title":"Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases","volume":"27","author":"Glitza","year":"2017","journal-title":"Melanoma Res"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1097\/SCS.0000000000003874","article-title":"Bevacizumab for the treatment of gammaknife radiosurgery-induced brain radiation necrosis","volume":"28","author":"Ma","year":"2017","journal-title":"J Craniofac Surg"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11060-014-1488-0","article-title":"A new strategy of CyberKnife treatment system-based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema","volume":"119","author":"Wang","year":"2014","journal-title":"J Neurooncol"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"e14182","DOI":"10.1097\/MD.0000000000014182","article-title":"Significant response of low-dose apatinib monotherapy in brain metastases of triple-negative breast cancer: a case report","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1200\/JCO.2015.63.5995","article-title":"Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction","volume":"34","author":"Li","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:45:52Z","timestamp":1694835952000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022925"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":18,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022925","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}